ImmunityBio, Inc. (IBRX)
7.575
-0.22
(-2.76%)
USD |
NASDAQ |
Aug 24, 16:00
7.52
-0.06
(-0.73%)
After-Hours: 19:54
ImmunityBio 1 Year Total Returns (Daily) : 247.8% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 247.8% |
| August 20, 2026 | 246.9% |
| August 19, 2026 | 256.6% |
| August 18, 2026 | 217.7% |
| August 17, 2026 | 210.6% |
| August 14, 2026 | 179.3% |
| August 13, 2026 | 171.3% |
| August 12, 2026 | 213.4% |
| August 11, 2026 | 207.7% |
| August 10, 2026 | 207.0% |
| August 07, 2026 | 217.7% |
| August 06, 2026 | 207.6% |
| August 05, 2026 | 200.8% |
| August 04, 2026 | 188.4% |
| August 03, 2026 | 201.7% |
| July 31, 2026 | 191.5% |
| July 30, 2026 | 191.0% |
| July 29, 2026 | 168.9% |
| July 28, 2026 | 163.0% |
| July 27, 2026 | 144.4% |
| July 24, 2026 | 135.9% |
| July 23, 2026 | 147.5% |
| July 22, 2026 | 177.1% |
| July 21, 2026 | 201.1% |
| July 20, 2026 | 172.5% |
| Date | Value |
|---|---|
| July 17, 2026 | 171.4% |
| July 16, 2026 | 170.9% |
| July 15, 2026 | 182.1% |
| July 14, 2026 | 171.7% |
| July 13, 2026 | 177.2% |
| July 10, 2026 | 186.4% |
| July 09, 2026 | 217.9% |
| July 08, 2026 | 224.7% |
| July 07, 2026 | 222.1% |
| July 06, 2026 | 227.6% |
| July 02, 2026 | 257.6% |
| July 01, 2026 | 258.0% |
| June 30, 2026 | 231.6% |
| June 29, 2026 | 224.8% |
| June 26, 2026 | 212.2% |
| June 25, 2026 | 182.2% |
| June 24, 2026 | 179.6% |
| June 23, 2026 | 165.2% |
| June 22, 2026 | 151.6% |
| June 18, 2026 | 159.2% |
| June 17, 2026 | 146.1% |
| June 16, 2026 | 114.7% |
| June 15, 2026 | 132.2% |
| June 12, 2026 | 122.6% |
| June 11, 2026 | 122.2% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Sarepta Therapeutics, Inc. | -6.33% |
| Cogent Biosciences, Inc. | 212.1% |
| Moderna, Inc. | 453.5% |
| Arrowhead Pharmaceuticals, Inc. | 319.8% |
| Oncolytics Biotech, Inc. | -16.52% |